Neurofibromatosis type 1 with generalized pruritus
Keywords:
Neurofibromatosis, pruritusAbstract
Neurofibromatosis is a neurocutaneous condition that can involve almost any organ system. Presenting signs and symptoms may vary widely. We describe a patient who presented with generalized pruritus that was not responding to conventional antihistamines or topical steroids, but responded very well to ketotifen. A brief review of the disorder is also made.References
Morse RP. Neurofibromatosis type 1. Arch Neurol 1999; 56: 364-5.
Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 1988; 45: 575-8
Karnes PS. Neurofibromatosis: a common neurocutaneous disorder. Mayo Clin Proc 1998; 73:1071-6.
von Recklinghausen FD. Ueber die Multiplen Fibrome der Haut and Ihre Beziehung zu den Multiplen Neuromen. Berlin: Festschrift fur Rudolf Virchow; 1882.
Barker D, Wright E, Nguyen K et al. Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science 1987; 236: 1100-3
Gutmann DH: Recent insights into neurofibromatosis type 1: clear genetic progress. Arch Neurol 1998; 55: 778-80
Lazaro C, Ravella A, Gaona A et al. Neurofibromatosis type 1 due to germ line mosaicism in a clinically normal father. N Engl J Med 1994; 331: 1403-7.
Riccardi VM, ed. Neurofibromatosis: phenotype, natural history, and pathogenesis, 2nd edn. Baltimore: John Hopkins University Press; 1992.
Hope DJ, Mulvihill JJ. Malignancy in neurofibromatosis. Adv Neurol 1981; 29: 33-56.
Gutmann DH, Aylsworth A, Carey JC et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis types 1 and 2. JAMA 1997; 278: 51-7.
Nurnberger M, Moll I. Semiquantitative aspect of mast cells and in neurofibromas of neurofibromatosis type 1 and 5. Dermatology 1994; 188: 296-9.
Riccardi VM. Mast cell stabilization to decrease neurofibroma growth. Preliminary experience with ketotifen. Arch Dermatol 1988; 123: 1011-6.
Riccardi VM. A controlled multiphase trial of ketotifen to minimize neurofibroma-associated pain and itching. Arch Dermatol 1993; 129: 577-81.
